Abstract Carbapenem resistance in gram-negative bacteria by production of carbapenemases is one of the most challenging issues regarding healthcare worldwide. We review the epidemiology and prevalence of carbapenemases in carbapenem-resistant Acinetobacter baumannii isolates from Latin American countries. High resistance rates to antimicrobial agents, particularly to carbapenems, are observed in this region. OXA-23 is the most widely disseminated class D-carbapenemase; it is present in all the countries of the region and is frequently associated to endemic clones CC113/CC79, CC104/CC15, CC110/ST25 and CC109/CC1. The emergence of OXA-72 and NDM-1 represents a novel finding which is observed simultaneously and without clonal relatedness in different countries, some of which are distant from one another, whereas OXA-143 is only present in Brazil. Further collaborative intraregional studies would provide a better understanding of these issues in most of the countries and thus, policies to control the spread of these isolates could be implemented. Resumen En bacilos gram negativos, la resistencia a carbapenemes por producción de carbapenemasas es uno de los mayores problemas en la atención de la salud a nivel mundial. Reseñamos en este artículo la epidemiologia y la prevalencia de las carbapenemasas descritas en aislamientos de Acinetobacter baumannii recuperados en América Latina. En esta región se ha observado un alto porcentaje de resistencia a los antimicrobianos, particularmente a
Introduction
The genus Acinetobacter, as currently defined, comprises gram-negative, strictly aerobic, nonfermenting, nonfastidious, nonmotile, catalase-positive, oxidase-negative bacteria with a DNA G+C content of 39---47% 24 . Implementation of molecular techniques and mass spectrometry such as matrix-assisted laser desorption ionization-time and flight mass spectrometry (MALDI-TOF MS) in clinical microbiology laboratories has greatly improved the identification of Acinetobacter species. Acinetobacter baumannii is the most important in the clinical context. This is the genospecies which is most frequently associated with hospital outbreaks 24 . The ability to survive on inanimate surfaces and resistance to disinfectants or antimicrobials are crucial to this behavior 24 . Carbapenems are currently the antibiotics of choice against multidrug-resistant Acinetobacter infections. However, carbapenem-resistance (CR) is increasingly being reported, leaving few therapeutic options available 24, 37, 38 . The aim of this review is to analyze the prevalence and molecular epidemiology of carbapenem-resistant A. baumannii (CR-Ab) isolates in Latin American countries.
Literature associated with CR-Ab in Latin America (LA) was included. The articles in English and Spanish language were accessed through PubMed and Scientific Electronic Library Online (SciELO). Pan American Health Organization (PAHO) documents were also consulted 19---23 . It is important to mention that a heterogeneous distribution of molecular epidemiology studies performed in the region was noticed; although 60% of the countries in LA have presented data, more than 50% of these correspond to Brazil and Argentina.
Prevalence of carbapenem-resistant

A. baumannii
Rates of carbapenem resistance in LA appear to be among the highest in the world. A wide range of resistance has been reported among the different countries (1---90%), the lowest values belong to Central America and the highest ones to some studies in Argentina and Brazil 12 . In addition, reports of the Latin American Antimicrobial Resistance Surveillance Network (ReLAVRA-PAHO) showed a progressive increase in Argentina  17  16  27  78  82  Bolivia  19  53  Brazil  14  56  33  Chile  30  Colombia  32  60  56  Costa Rica  3  Cuba  66  Ecuador  27  21  8  54  83  El Salvador  17  11  19  46  Guatemala  33  45  40  64  46  Honduras  27  23  28  México  4  59  Nicaragua  6  6  15  79  Panamá  27  77  78  Paraguay  10  33  63  77  Perú  78  R. Dominicana  22  20  20  Uruguay  36  Venezuela  20  31  46  33  73 the percentages of resistance reported during the period 2000---2013 19---23 (Table 1) . Even though statistics do not show discrimination among genospecies, some studies conducted in the area evidence a participation of A. baumannii in nosocomial infections higher than 90% 27 . Therefore, it could be affirmed that resistance rates would not vary significantly if only A. baumannii isolates had been considered in the analysis 27 .
Carbapenem resistance
Acquired carbapenem resistance in Acinetobacter spp. is often associated with acquired carbapenemase production. The most frequent ones are carbapenem-hydrolyzing class D ␤-lactamases (CHDLs) and secondly, metalloenzymes (MBL) such as VIM, IMP and NDM 37, 38 . The first reported OXA-type enzyme was a plasmidencoded ␤-lactamase described in 1985 that was initially named ARI-1 and later OXA-23 24, 37 . The bla OXA-23 gene can be located either on the chromosome or on plasmids 37 . This carbapenemase was the first described in LA in addition to being the most frequently reported and geographically most disseminated in LA. Its presence has been reported in all the Latin American countries where molecular epidemiology studies have been published (Table 2 and Fig. 1 ).
OXA-type carbapenemases
The worldwide dissemination of bla OXA-23 would be related to International clones I or II. In South America (SA) this carbapenemase has been commonly associated with CC113/CC79; however, it has also been detected in clones recovered in a lower proportion (CC104/CC15, CC110/ST25, CC109/CC1) and in many sporadic isolates 3,6,9,14---17,28---30,34,36 . Some OXA-23 allelic variants, such as OXA-239, have been described, which showed a major presence in studies conducted in the south of Mexico in the year 2014 1 . As it can be observed in Figure 1 , OXA-23 predominates in all the countries of the region, it is the most frequently detected carbapenemase in the CR-Ab population, except for some studies carried out in the south of Mexico 1,4 . In the mid-1990s, bla OXA-58 was reported in Argentina and Venezuela 2, 32 . Ten years later, outbreaks by CR-Ab have shown the presence of OXA-58 as the main carbapenemresistance mechanism in Bolivia and Chile 5, 18 . Coincidentally to what has been detected in other regions in recent years, a total displacement of bla OXA-58 by bla OXA-23 was observed in LA. In Argentina, the presence of OXA-58 in the resistant population has gradually declined from 36% in 1995 to 0% in studies conducted after the year 2014 28 . It is also noteworthy to mention the low presence of this carbapenemase in Brazil, where the first isolate harboring OXA-58 was recovered in the year 2007, and so far, has only been detected sporadically 8, 36 . In Brazil and Bolivia bla OXA-58 -producing isolates belonged to CC113/CC79, reaffirming its important presence in the CR-Ab population of LA, whereas in Argentina some strains were found to be associated to CC109/CC1 5, 8, 28 .
The fact that both carbapenemases have been described in the same STs suggests that the prevalence of one enzyme over another does not only depend exclusively on the clone, but also on the ability to acquire resistance through horizontal gene transfer and the impact on the MIC value of the antimicrobial agents affected, among other factors 5, 9, 14, 29, 30, 34, 36 . Earlier, Opazo et al. 18 reported the presence of CR-Ab isolates belonging to the 24/40 group in LA, however, unfortunately, they were not sequenced. This carbapenemase, often plasmid-mediated, has been reported to cause hospital outbreaks in many Intensive Care Units (ICUs) worldwide 37 . In LA sporadic isolates were described in Brazil and Colombia in the middle of the last decade 3, 31 . Since 2010 the first outbreaks have been detected in Guayaquil, Ecuador (2012) and in Brazil (2014). These isolates belonged to ST15 and CC113/CC79 in Ecuador and Brazil, respectively 17, 36 . In Mexico, on the other hand, OXA-72 seems to be the most important contributor to carbapenem resistance in A. baumannii in several studies conducted in different cities in the north and center of the country 1, 4 . Two new CHDL variants, OXA-143 and OXA-235, have been described in the last 10 years in LA; OXA-143, of plasmid encoding, possesses 40% similarity with OXA-40; there are two variants of this enzyme: OXA-231 and OXA-253 11 . As the bla OXA-143 gene is undetectable using the current multiplex PCR assay available, Higgins et al. showed a modified multiplex PCR which can help to monitor the spread of this carbapenemase 20 . OXA-143 was detected for the first time in 2004 and to date, it has only been isolated in Brazil, its presence in the south of that country reaching about 70%. bla like genes mainly belong to clonal complexes CC104/CC15, CC109/CC1 and CC113/CC79 3,7,10,16 . On the other hand, OXA-235 hydrolyzes penicillins and carbapenems but it does not show activity against extendedspectrum cephalosporins. Only one strain was isolated in Mexico in 2016 11 .
Metallo-␤-lactamase carbapenemases
Metallo-␤-lactamases are divided into six families; of these, only IMP, VIM, SIM and NDM enzymes have been detected in A. baumannii 38 . We can differentiate 2 periods regarding the presence of MBLs in LA. The first period started in the mid-1990s, with the detection of IMP-1 in Brazil 35 . Even though more than 15 years have passed and that more allelic variants have been detected (IMP-10), these isolates have been restricted to a few hospitals located in e Sao Pablo State 6 . Apart from Brazil, sporadic isolates harboring bla IMP , blav IM-1 and bla VIM-4 have been described in Mexico 1, 4 . The second period started with the detection of the bla NDM-1 gene almost simultaneously in Honduras (2012) and Brazil (2013) in A. baumannii isolates belonging to ST25 25, 39 . Later in the following years, its presence was communicated in Argentina, Colombia, Nicaragua and Paraguay 21---23 . Moreover, this enzyme was also detected in other genospecies different from A. baumannii as well as in Enterobacteriaceae. 
Other carbapenemases
Carbapenemases different from CHDLs and MBLs are rare in A. baumannii 24 . However, it is noteworthy to mention the importance of the presence of KPC in A. baumannii isolates recovered in Puerto Rico [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The possibility of transmission of multidrug-resistant A. baumannii by tourism and/or human migration is a widely described phenomenon in A. baumannii. Therefore, the important interrelationship between the Caribbean country and SA would imply the need to implement measures to detect this enzyme in A. baumannii.
In the comparative analysis of the 2 symmetric periods shown in Figure 1 , it can be observed that OXA-23 is the carbapenemase/oxacillinase mostly present in both periods (1990---2003 and 2006---2016) , whereas OXA-58 was mainly detected in the first period and OXA-72; OXA-143 and NDM in the second one.
Clonal dissemination
Different tools have been proposed to investigate the epidemiology of A. baumannii outbreaks. Pulsed-field electrophoresis (PFGE) has been considered the gold-standard technique for fine-scale typing of A. baumannii isolates. The presence of multiple clones has been detected in most of the studies conducted in one hospital unit, which evidences endemic features in the CR-Ab population in LA. Conversely, the multilocus sequence typing technique (MLST) has a better ability to group isolates during large-sized epidemiological analyses. bla OXA-51-like sequence-based typing and 3-locus sequence typing represent economic and rapid methodologies which show a discriminatory power similar to MLST. Most recently, MALDI-TOF has shown to behave less effectively to perform A. baumannii clonal discrimination 24 .
Despite the widely-accepted idea that a few genotypic groups are responsible for a large proportion of A. baumannii infections, particular characteristics of each region have been reported. Contrary to what was reported in Europe and other countries worldwide, in LA, the presence of the international clones II and III represented a minority in the year 2016 7, 8, 14, 24, 29, 30, 34, 36 . Research performed in SA has shown a predominance of CC113/CC79. Stietz et al. 34 evidenced its presence in isolates recovered before the year 2000 in a retrospective study. Subsequent studies carried out mainly in Brazil, but also in Argentina and Colombia, confirmed the predominance of CC113/CC79 together with CC103/CC15 and CC109/CC1 in CR-Ab isolates 7, 8, 14, 30, 34, 36 . In the year 2014 the first plurinational study performed in LA, which involved 9 hospitals belonging to 6 countries, evidenced that its predominance was also extended to countries such as Chile, Uruguay, Paraguay and Ecuador 29 . The spread of ST25 was also highlighted in the mentioned study in different LA countries, similarly to what was observed in other regions 12, 29, 30, 34 .
Summary
The main findings and recent changes in the molecular epidemiology of carbapenem-resistant A. baumannii clinical isolates in LA were revised in the present study. Among them, we have observed common features with other regions: (1) A. baumanii represents the predominant genospecies; (2) the main presence of A. baumanii in nosocomial infections and the progressive increase in carbapenem resistance rates; (3) the high prevalence of the bla OXA-23 gene; (4) the emergence of OXA-72 and NDM-1, and other features such as the low predominance of international clones I, II and III. Therefore, we believe that being able to obtain our own results and figures will lead to the elaboration of a regional casuistic report, which would guide the implementation of the adequate policies to prevent and/or control the spread of multidrug-resistant A. baumannii isolates.
